| Nov 21, 2024 | www.prnewswire.com | BioLineRx and Ayrmid Ltd. Enter into Exclusive License Agreement to Commercialize APHEXDA® (motixafortide) through Gamida Cell Ltd. |
| May 12, 2024 | www.jpost.com | Gamida Cell has a second chance to be an Israeli success story |
| Apr 8, 2024 | finance.yahoo.com | XORTX Welcomes New Member to the Board of Directors |
| Apr 1, 2024 | finance.yahoo.com | Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive |
| Mar 28, 2024 | finance.yahoo.com | Q4 2023 Gamida Cell Ltd Earnings Call |
| Mar 27, 2024 | finance.yahoo.com | Gamida Cell Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Company Update |
| Mar 27, 2024 | finance.yahoo.com | Gamida Cell Announces Commencement of Restructuring Process Supported by Highbridge Capital Management |
| Mar 26, 2024 | www.globenewswire.com | Gamida Cell Announces Commencement of Restructuring Process Supported by Highbridge Capital Management |
| Mar 26, 2024 | en.globes.co.il | Gamida Cell to delist as Highbridge takes full ownership |
| Mar 26, 2024 | www.fiercebiotech.com | Unable to find a partner for stem cell therapy, Gamida accepts sale to investment firm to survive |
| Mar 22, 2024 | finance.yahoo.com | Gamida Cell to Report Fourth Quarter and Full-Year 2023 Financial Results |
| Feb 23, 2024 | finance.yahoo.com | Gamida Cell Data Presented at the 2024 Tandem Meetings of ASTCT® and CIBMTR® |
| Jan 29, 2024 | finance.yahoo.com | Gamida Cell Actively Pursuing Strategic Alternatives |
| Jan 17, 2024 | finance.yahoo.com | Gamida Cell to Present at the 2024 Tandem Meetings of ASTCT® and CIBMTR® |
| Nov 28, 2023 | finance.yahoo.com | Gamida Cell to Host Virtual Thought Leader Fireside Chat on December 4, 2023 |
| Nov 20, 2023 | finance.yahoo.com | Gamida Cell to Present Corporate Highlights at the Piper Sandler 35th Annual Healthcare Conference |
| Nov 15, 2023 | finance.yahoo.com | Gamida Cell Ltd. (NASDAQ:GMDA) Q3 2023 Earnings Call Transcript |
| Nov 15, 2023 | finance.yahoo.com | Q3 2023 Gamida Cell Ltd Earnings Call |
| Nov 14, 2023 | finance.yahoo.com | Gamida Cell Reports Third Quarter 2023 Financial Results and Provides Company Update |
| Nov 4, 2023 | finance.yahoo.com | Gamida Cell Presents New Data on Allogeneic Stem Cell Therapy Omidubicel and Natural Killer (NK) Cell Therapy Candidate GDA-201 at Society for Immunotherapy of Cancer (SITC) Annual Meeting |
| Nov 1, 2023 | finance.yahoo.com | Gamida Cell to Report Third Quarter 2023 Financial Results |
| Oct 16, 2023 | www.businesswire.com | Gamida Cell Reports Preliminary Data from Phase 1 Study of Natural Killer (NK) Cell Therapy Candidate GDA-201 |
| Oct 9, 2023 | www.businesswire.com | Gamida Cell Issues Update on Israel Operations |
| Oct 2, 2023 | www.businesswire.com | Gamida Cell to Present Corporate Highlights at 2023 Cell & Gene Meeting on the Mesa |
| Sep 29, 2023 | finance.yahoo.com | Pleasing Signs As A Number Of Insiders Buy Gamida Cell Stock |
| Sep 28, 2023 | www.businesswire.com | Gamida Cell to Present at Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting |
| Sep 27, 2023 | www.businesswire.com | First Patient Receives Gamida Cell's Omisirge™ (omidubicel-onlv) |
| Aug 31, 2023 | www.businesswire.com | Gamida Cell to Present Corporate Highlights at the H.C. Wainwright 25th Annual Global Investment Conference |
| Aug 19, 2023 | finance.yahoo.com | Retail investors account for 54% of Gamida Cell Ltd.'s (NASDAQ:GMDA) ownership, while institutions account for 29% |
| Aug 15, 2023 | finance.yahoo.com | Q2 2023 Gamida Cell Ltd Earnings Call |
| Aug 14, 2023 | www.businesswire.com | Gamida Cell Reports Second Quarter and First Half 2023 Financial Results and Provides Company Update |
| Aug 1, 2023 | www.businesswire.com | Gamida Cell to Report Second Quarter 2023 Financial Results |
| Jul 11, 2023 | www.businesswire.com | Data Published in Transplantation and Cellular Therapy Suggest Antiviral Protection After Transplantation with Gamida Cell’s Omisirge® (omidubicel-onlv) |
| Jul 10, 2023 | finance.yahoo.com | STAND UP TO CANCER NAMES JULIAN ADAMS, Ph.D., CHIEF SCIENCE OFFICER |
| Jun 20, 2023 | finance.yahoo.com | Here's Why Gamida Cell (GMDA) Looks Ripe for Bottom Fishing |
| Jun 14, 2023 | www.businesswire.com | Gamida Cell To Host Investor Day |
| Jun 9, 2023 | finance.yahoo.com | Gamida Cell (GMDA)'s Technical Outlook is Bright After Key Golden Cross |
| May 31, 2023 | www.businesswire.com | Data To Be Presented on Gamida Cell Natural Killer (NK) Cell Therapy Candidate GDA-201 at the International Society for Cell & Gene Therapy 2023 Annual Meeting |
| May 31, 2023 | www.businesswire.com | Gamida Cell to Present Corporate Highlights at the Jefferies Healthcare Conference |
| May 22, 2023 | www.businesswire.com | Gamida Cell Appoints Terry Coelho as CFO |
| May 17, 2023 | finance.yahoo.com | Breakeven On The Horizon For Gamida Cell Ltd. (NASDAQ:GMDA) |
| May 15, 2023 | www.businesswire.com | Gamida Cell Reports First Quarter 2023 Financial Results and Provides Company Update |
| May 11, 2023 | www.businesswire.com | Gamida Cell Announces the Date of Its First Quarter 2023 Financial Results and Webcast |
| Apr 20, 2023 | finance.yahoo.com | Insiders who bought into Gamida Cell Ltd. (NASDAQ:GMDA) earlier this year might wish they'd invested more as stock gained 113% |
| Apr 20, 2023 | www.sponser.co.il | אחרי הזינוק: גמידה סל תגייס 23 מיליון דולר, כת”ב תדולל |
| Apr 19, 2023 | www.businesswire.com | Gamida Cell Announces Pricing of $23 Million Public Offering of Securities |
| Apr 18, 2023 | www.businesswire.com | Gamida Cell Announces Launch of Public Offering of Securities |
| Apr 18, 2023 | en.globes.co.il | Gamida Cell surges after FDA approves cancer treatment |
| Apr 18, 2023 | finance.yahoo.com | Gamida Cell (GMDA) Surges on FDA Approval for Omisirge |
| Apr 17, 2023 | www.businesswire.com | Gamida Cell's Allogeneic Cell Therapy Omisirge® (omidubicel-onlv) Receives FDA Approval |
| Apr 17, 2023 | www.businesswire.com | Gamida Cell’s Allogeneic Cell Therapy Omisirge® (omidubicel-onlv) Receives FDA Approval |
| Mar 29, 2023 | finance.yahoo.com | Gamida Cell Ltd. (NASDAQ:GMDA) Q4 2023 Earnings Call Transcript |
| Mar 28, 2023 | finance.yahoo.com | Israeli-Boston cell therapy firm lays off nearly one-fifth of workforce |
| Mar 27, 2023 | www.businesswire.com | Gamida Cell Reports Full Year 2022 Financial Results and Provides Company Update |
| Mar 20, 2023 | www.businesswire.com | Gamida Cell Announces the Date of Its Fourth Quarter and Full Year 2022 Financial Results and Webcast |
| Mar 20, 2023 | www.businesswire.com | Gamida Cell Announces Changes to Board of Directors |
| Mar 12, 2023 | finance.yahoo.com | Gamida Cell Ltd.'s (NASDAQ:GMDA) largest shareholders are retail investors with 44% ownership, institutions own 29% |
| Mar 7, 2023 | www.businesswire.com | Gamida Cell to Present Corporate Highlights at the Oppenheimer 33rd Annual Healthcare Conference |
| Feb 18, 2023 | www.businesswire.com | Data Presented on Gamida Cell’s Omidubicel, GDA-201 at the 2023 Tandem Meetings of ASTCT and CIBMTR |
| Nov 3, 2022 | www.businesswire.com | Gamida Cell Announces Omidubicel Data To Be Presented as an Oral Presentation at 64th ASH Annual Meeting |
| Sep 29, 2022 | www.businesswire.com | Long-Term Data from Omidubicel Phase 3 Trial Demonstrates Overall Survival and Sustainable Durable Outcomes for Patients with Blood Cancers at the Society of Hematologic Oncology Meeting |
| Aug 10, 2022 | www.businesswire.com | Gamida Cell Announces Dosing of First Patient in Company-Sponsored Phase 1/2 Study of NK Cell Therapy Candidate GDA-201 |
| Aug 1, 2022 | www.businesswire.com | Gamida Cell Announces FDA Acceptance of Biologics License Application for Omidubicel with Priority Review |
| Jun 2, 2022 | www.businesswire.com | Gamida Cell Completes Rolling Biologics License Application Submission to the FDA for Omidubicel |
| Jan 19, 2022 | www.businesswire.com | Gamida Cell Provides Update on Omidubicel BLA Submission |
| Jun 7, 2021 | www.businesswire.com | Gamida Cell Announces Appointment of Senior Vice President, Global Operations and Manufacturing and Provides Commercial Manufacturing Update |
| Mar 1, 2021 | www.businesswire.com | Gamida Cell Announces Results from Phase 3 Study of Omidubicel to be Presented at the 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) |
| Feb 16, 2021 | www.calcalistech.com | Gamida Cell announces $75 million financing with Highbridge Capital Management |
| Dec 20, 2020 | www.sponser.co.il | גמידה סל מצטרפת למדד הביוטכנולוגיה של ה-Nasdaq |
| Dec 16, 2020 | www.businesswire.com | Gamida Cell Announces Launch of Public Offering of Ordinary Shares |
| Oct 13, 2020 | www.biospace.com | Gamida Cell and Be The Match BioTherapies® Expand Strategic Collaboration BioSpace |
| Oct 11, 2020 | www.jpost.com | https://www.jpost.com/health-science/israeli-company-sees-promising-results-in-blood-cancer-treatment-trial-645311 |
| Sep 3, 2020 | www.businesswire.com | Gamida Cell Announces Two-Part Virtual Miniseries Focused on Omidubicel to Take Place in September |
| May 19, 2020 | en.globes.co.il | Gamida Cell raises $60m at 24% discount |
| May 12, 2020 | en.globes.co.il | Bone marrow co Gamida Cell reports positive Phase III results |
| Jul 1, 2019 | en.globes.co.il | Gamida Cell raises $35m;share plummets 30% |
| Jun 20, 2019 | www.pharmaceutical-business-review.com | Gamida Cell, Lonza establish commercial manufacturing agreement for omidubicel - Pharmaceutical Business review |
| Jun 5, 2019 | www.biospace.com | Gamida Cell Bolsters Management Team with Appointment of Tracey Lodie, Ph.D., as Chief Scientific Officer BioSpace |
| May 31, 2019 | www.businesswire.com | Gamida Cell Announces Data for Omidubicel Presented at the International Society for Cellular and Gene Therapy 2019 Annual Meeting |
| Mar 21, 2019 | www.businesswire.com | Gamida Cell Nominates Two Healthcare Industry Veterans to Its Board of Directors |
| Feb 21, 2019 | www.biospace.com | Gamida Cell Presents New Data from Ongoing Phase 1 Study of NAM-NK and Initial Data from Phase 1/2 Study of NiCord® in Severe Aplastic Anemia at 2019 TCT Annual Meeting BioSpace |
| Feb 19, 2019 | www.biospace.com | Gamida Cell Announces Agreement with Editas Medicine to Evaluate Use of CRISPR Genome Editing Technology in NAM-NK Cells BioSpace |
| Jan 29, 2019 | lymphomanewstoday.com | Gamida Cell, Be The Match BioTherapies Team Up on NiCord for Blood... |
| Jan 24, 2019 | www.businesswire.com | Gamida Cell Announces Data from NAM-NK and NiCord® Programs to Be Presented at 2019 TCT Annual Meeting |
| Jan 22, 2019 | www.marketwatch.com | https://www.marketwatch.com/press-release/gamida-cell-and-be-the-match-biotherapies-announce-strategic-collaboration-2019-01-22 |
| Oct 28, 2018 | en.globes.co.il | Gamida Cell raises $50m in Nasdaq IPO |
| Oct 17, 2018 | en.globes.co.il | Novartis to invest in $60m Gamida Cell Nasdaq IPO |
| Sep 30, 2018 | www.calcalistech.com | Biotech Company Gamida Cell Files for $69 Million Nasdaq IPO |
| Sep 2, 2018 | en.globes.co.il | Gamida Cell files for Nasdaq IPO |
| Aug 6, 2018 | www.gamida-cell.com | Press Releases - Investors - Gamida Cell Ltd. |
| Dec 13, 2017 | www.globes.co.il | Gamida Cell reports positive cancer drug trial |
| Jul 20, 2017 | www.prnewswire.com | Gamida Cell Announces $3.5 Million Grant from the Israeli Government |
| Jul 10, 2017 | www.prnewswire.com | Gamida Cell Inc. Names Ronit Simantov, M.D. as Chief Medical Officer |
| Jun 19, 2017 | www.reuters.com | Israel's Gamida Cell raises $40 million for bone marrow trial |
| Mar 8, 2017 | www.globes.co.il | Investment fund leading $30m Gamida Cell round |
| Dec 6, 2016 | www.gamida-cell.com | http://www.gamida-cell.com/press_item.asp?ID=71&t=Gamida-Cell-Presents-Positive-Data-From-Phase-1/2-Study-of-NiCord%C2%AE-as-a-Curative-Treatment-for-Sickle-Cell-Disease-at-ASH-2016 |
| Oct 14, 2015 | www.geektime.co.il | גיוס: Gamida Cell הישראלית מגייסת 15 מיליון דולר מ-Novartis |
| May 15, 2012 | www.finsmes.com | Gamida Cell Closes $10m Series E Financing - FinSMEs |
| Sep 27, 2006 | en.globes.co.il | Gamida Cell raises $16m in fourth financing round |